Pettersen Kjell I, Reikvam Aasmund, Stavem Knut
Quality Evaluation Department, Norwegian Health Services Research Centre, Nordbyhagen, Norway.
Qual Life Res. 2005 Apr;14(3):883-9. doi: 10.1007/s11136-004-0802-2.
The aim of this study was to validate the Norwegian version of the Seattle Angina Questionnaire (SAQ), a self-administered 19-item questionnaire designed to assess health-related quality of life in patients with chest pain or coronary artery disease. In 885 patients with prior myocardial infarction (MI), we abstracted clinical data from the patients' medical records. Two to three years after the MI, we mailed a self-administered questionnaire including the SAQ, the Short Form 36 (SF-36), and questions about current medication, to the 548 patients still alive. The response rate was 74%. Internal consistency reliability of the SAQ, assessed with Cronbach's alpha, ranged 0.75-0.92. Test-retest reliability, tested with an intraclass correlation coefficient, ranged 0.29-0.84. The pattern of association between similar and dissimilar scales of the SAQ and SF-36 mainly supported the construct validity of the SAQ. Four of the five SAQ scales discriminated between patients with different medication regimens as a proxy for severity of angina pectoris. We conclude that the Norwegian version of the SAQ showed acceptable reliability and cross-sectional validity following MI, with properties in line with the original US version.
本研究的目的是验证西雅图心绞痛问卷(SAQ)的挪威语版本,这是一份包含19个条目的自填式问卷,旨在评估胸痛或冠状动脉疾病患者的健康相关生活质量。在885例既往有心肌梗死(MI)的患者中,我们从患者的病历中提取了临床数据。心肌梗死后两到三年,我们向仍在世的548例患者邮寄了一份自填式问卷,其中包括SAQ、简短健康调查问卷(SF-36)以及有关当前用药情况的问题。应答率为74%。用Cronbach's alpha评估的SAQ内部一致性信度在0.75至0.92之间。用组内相关系数检验的重测信度在0.29至0.84之间。SAQ和SF-36相似及不同量表之间的关联模式主要支持了SAQ的结构效度。SAQ的五个量表中有四个能够区分不同用药方案的患者,以此作为心绞痛严重程度的替代指标。我们得出结论,SAQ的挪威语版本在心肌梗死后显示出可接受的信度和横断面效度,其特性与原始的美国版本一致。